Why you care about these people is beyond me. It seems to me the better discipline is to ignore them and continue to discuss CRIS analytically. I have held this stock for quite a while and will continue to do so though I am kicking myself because I had a target of $5.50 at the end of the year and when it came early last month I did not take some profit and get back in now. This downward trend has to be attributed to lower than expected revenue from Erivedge, just due to the sheer number for second quarter, $10,000,000. If you believe as I do that BCC is going to be around for a long time and from all accounts is growing, Erivedge will be the solution for that small percentage of BCC patients who need to shrink their tumors because they are inoperable or to make them more operable. If Europe comes through as well as Australia, then Japan,etc. three years from now the whole planet will have access to Erivedge which should bode well for Curis. Two years ago this stock was below $2 and investors were frightened to touch it. Today's price is as inviting, so I am going to add a little to my disproportionately large holding in Curis based on my belief a year from now it will have exceeded $5.50.
Tarheel, sure, they are easy to ignore, thier content is 0.00 value, but it does trouble me that they take up so much space and drive serious posters/readers away. Ignore is not getting rid of them for me. . . I been ignoring all the way back to jwashington, but these punks just keep reappearing. Now; about that $5.50, I have the same regrets you have there - - makes me wonder if a big resistance level at $5.50 will be hard to crack in the future? I'll defer to the chartists. GL